MX367209B - Una composición intravenosa que comprende ibuprofeno y paracetamol en combinación. - Google Patents

Una composición intravenosa que comprende ibuprofeno y paracetamol en combinación.

Info

Publication number
MX367209B
MX367209B MX2015008709A MX2015008709A MX367209B MX 367209 B MX367209 B MX 367209B MX 2015008709 A MX2015008709 A MX 2015008709A MX 2015008709 A MX2015008709 A MX 2015008709A MX 367209 B MX367209 B MX 367209B
Authority
MX
Mexico
Prior art keywords
approximately
combination
combination composition
paracetamol
ibuprofen
Prior art date
Application number
MX2015008709A
Other languages
English (en)
Inventor
Campbell Atkinson Hartley
Original Assignee
Aft Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46024668&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX367209(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aft Pharmaceuticals Ltd filed Critical Aft Pharmaceuticals Ltd
Publication of MX367209B publication Critical patent/MX367209B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Una composición intravenosa para proporcionar alivio del dolor y/o la inflamación, conteniendo la composición ibuprofeno y paracetamol combinados para suministrar a un ser humano en cada dosis: a) de aproximadamente 125 mg a aproximadamente 175 mg de ibuprofeno combinados con de aproximadamente 475 mg a aproximadamente 525 mg de paracetamol; o b) de aproximadamente 275 mg a aproximadamente 325 mg de ibuprofeno combinados con de aproximadamente 975 mg a aproximadamente 1025 mg de paracetamol.
MX2015008709A 2010-11-04 2011-10-26 Una composición intravenosa que comprende ibuprofeno y paracetamol en combinación. MX367209B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ58901110 2010-11-04
PCT/NZ2011/000226 WO2012060719A1 (en) 2010-11-04 2011-10-26 A combination composition

Publications (1)

Publication Number Publication Date
MX367209B true MX367209B (es) 2019-07-22

Family

ID=46024668

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2013005113A MX2013005113A (es) 2010-11-04 2011-10-26 Una composicion combinada.
MX2015008709A MX367209B (es) 2010-11-04 2011-10-26 Una composición intravenosa que comprende ibuprofeno y paracetamol en combinación.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2013005113A MX2013005113A (es) 2010-11-04 2011-10-26 Una composicion combinada.

Country Status (27)

Country Link
US (5) US20130225685A1 (es)
EP (1) EP2635269B1 (es)
JP (2) JP2013541583A (es)
KR (1) KR101900520B1 (es)
CN (2) CN107519159A (es)
AU (1) AU2011324137B2 (es)
BR (1) BR112013010829B8 (es)
CA (1) CA2814057C (es)
CL (1) CL2013001250A1 (es)
CO (1) CO6771406A2 (es)
CY (1) CY1123398T1 (es)
DK (1) DK2635269T3 (es)
ES (1) ES2742373T3 (es)
HR (1) HRP20191489T1 (es)
HU (1) HUE045442T2 (es)
LT (1) LT2635269T (es)
MX (2) MX2013005113A (es)
MY (1) MY160572A (es)
NZ (1) NZ609727A (es)
PH (1) PH12021550804A1 (es)
PL (1) PL2635269T3 (es)
PT (1) PT2635269T (es)
RS (1) RS59258B1 (es)
RU (2) RU2707089C2 (es)
SG (1) SG189319A1 (es)
SI (1) SI2635269T1 (es)
WO (1) WO2012060719A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013005113A (es) 2010-11-04 2013-06-03 Aft Pharmaceuticals Ltd Una composicion combinada.
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
WO2016008546A1 (en) * 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
KR20170066549A (ko) * 2014-10-06 2017-06-14 큠버랜드 파마슈티컬즈 인코포레이티드 통증 치료를 위한 이부프로펜과 아세트아미노펜의 공동 정맥 투여
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
EP3651721B1 (en) 2017-07-10 2024-09-04 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
US11197830B2 (en) * 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
US11568752B2 (en) * 2020-01-28 2023-01-31 David Clark Company Incorporated Gateway retrieval alert device for aircraft pushback operations
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3990895A (en) * 1995-12-05 1997-06-27 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic
AU2002224475B2 (en) * 2001-11-02 2008-01-17 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
KR101113005B1 (ko) * 2003-03-21 2012-02-24 맥네일-피피씨, 인코포레이티드 비-스테로이드계 항염증성 약물 투여법
SI1781277T1 (sl) * 2004-07-07 2012-07-31 Aft Pharmaceuticals Ltd Kombinirani sestavek ki vsebuje ibuprofen in paracetamol
KR20060072839A (ko) * 2004-12-23 2006-06-28 김경태 아세트아미노펜과 이부프로펜을 이용하여 통증조절과 해열작용을 하는 주사제
US7934627B2 (en) * 2005-10-13 2011-05-03 Alcoa Inc. Apparatus and method for high pressure extrusion with molten aluminum
EP2089013B1 (en) * 2006-10-20 2017-09-27 Johnson & Johnson Consumer Inc. Combination of acetaminophen with ibuprofen for the treament of pain
WO2008079818A2 (en) * 2006-12-21 2008-07-03 Soluprin Pharmaceuticals, Inc. Intravenous administration of water soluble analgesic formulations
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method
JP2012505830A (ja) * 2008-10-14 2012-03-08 エイエフティ ファーマスーティカルズ リミテッド 医薬品及び医薬品治療
CA2754922C (en) * 2009-03-12 2016-10-18 Cumberland Pharmaceuticals Inc. Administration of intravenous ibuprofen
WO2012005605A1 (en) * 2010-07-07 2012-01-12 Aft Pharmaceuticals Limited A combination composition comprising ibuprofen and paracetamol
MX2013005113A (es) 2010-11-04 2013-06-03 Aft Pharmaceuticals Ltd Una composicion combinada.
KR20170066549A (ko) * 2014-10-06 2017-06-14 큠버랜드 파마슈티컬즈 인코포레이티드 통증 치료를 위한 이부프로펜과 아세트아미노펜의 공동 정맥 투여

Also Published As

Publication number Publication date
CA2814057C (en) 2022-02-01
JP2013541583A (ja) 2013-11-14
US20240207210A1 (en) 2024-06-27
PT2635269T (pt) 2019-09-04
NZ609727A (en) 2015-07-31
ES2742373T3 (es) 2020-02-14
RU2015103107A3 (es) 2018-08-20
HUE045442T2 (hu) 2019-12-30
CL2013001250A1 (es) 2013-08-30
CN103298464A (zh) 2013-09-11
MY160572A (en) 2017-03-15
RU2013123646A (ru) 2014-12-10
PH12021550804A1 (en) 2022-02-14
BR112013010829A2 (pt) 2016-08-16
US11896567B2 (en) 2024-02-13
EP2635269A1 (en) 2013-09-11
US20160235695A1 (en) 2016-08-18
US11446266B2 (en) 2022-09-20
KR20140025314A (ko) 2014-03-04
HRP20191489T1 (hr) 2019-11-15
US20230000805A1 (en) 2023-01-05
CO6771406A2 (es) 2013-10-15
RU2015103107A (ru) 2015-06-20
KR101900520B1 (ko) 2018-09-19
RU2707089C2 (ru) 2019-11-22
WO2012060719A1 (en) 2012-05-10
LT2635269T (lt) 2019-09-10
AU2011324137B2 (en) 2015-05-07
SG189319A1 (en) 2013-05-31
DK2635269T3 (da) 2019-08-26
CN107519159A (zh) 2017-12-29
CY1123398T1 (el) 2021-10-29
RS59258B1 (sr) 2019-10-31
EP2635269B1 (en) 2019-05-22
AU2011324137A1 (en) 2013-05-02
JP6353577B2 (ja) 2018-07-04
MX2013005113A (es) 2013-06-03
SI2635269T1 (sl) 2019-10-30
JP2017132791A (ja) 2017-08-03
BR112013010829B8 (pt) 2022-01-04
EP2635269A4 (en) 2014-09-17
BR112013010829B1 (pt) 2021-12-21
PL2635269T3 (pl) 2019-11-29
US20130225685A1 (en) 2013-08-29
US20190029982A1 (en) 2019-01-31
CA2814057A1 (en) 2012-05-10

Similar Documents

Publication Publication Date Title
PH12021550804A1 (en) A combination composition
CY1116727T1 (el) Θεραπεια πολλαπλης σκληρυνσης me laquinimod
MY173215A (en) Acetylcysteine compositions and methods of use thereof
EA201290833A1 (ru) Применение амисульприда в качестве противорвотного средства
MX2013007189A (es) Metodos y composiciones adecuados para manejar glucosa en sangre en animales.
MX2011007589A (es) Tratamiento de un cancer usando una combinacion de bendamustine y un anticuerpo anti-cd20.
IL201479A (en) Use of tapentadol for the preparation of pain medication
MX2012007933A (es) Composiciones de dexmedetomidina transdermicas topicas y metodos para su uso.
MX2021013582A (es) Composiciones que comprenden agentes biologicamente activos y sales biliares.
MY173582A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof
IN2014DN08598A (es)
MY164112A (en) A combination composition comprising ibuprofen and paracetamol
WO2009012472A3 (en) Methods and compositions for treating conditions
MX2017005163A (es) Composiciones de liberación prolongada de onapristona y métodos.
MX2013010947A (es) Complejos de galio, composiciones farmacéuticas y métodos de uso.
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
TN2015000156A1 (en) Dispersible tablet
PH12015500070B1 (en) Pediatric oral liquid compositions containing nepadutant
MX366118B (es) Combinacion sinergistica de paracetamol/celecoxib para el tratamiento de dolor inflamatorio.
PH12019501607A1 (en) Tapentadol nasal composition
SA515360445B1 (ar) قرص قابل للتشتيت
TH152432A (th) องค์ประกอบแบบผสมผสาน
MY154883A (en) A combination composition
UA61955U (ru) Способ лечения больных эритематозно-буллезнОЙ бешихОЙ
UA59175U (ru) Способ медицинской реабилитации больных синдромом повышенной утомляемости